eXoZymes Inc. (NASDAQ:EXOZ - Get Free Report) shares were down 2.8% during trading on Thursday . The stock traded as low as $9.69 and last traded at $9.91. Approximately 1,256 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 10,423 shares. The stock had previously closed at $10.20.
eXoZymes Stock Up 2.7%
The company has a 50-day moving average of $12.44.
eXoZymes (NASDAQ:EXOZ - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported ($0.22) earnings per share (EPS) for the quarter.
About eXoZymes
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Read More
Before you consider eXoZymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.
While eXoZymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
